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Abstract
Objective—Oxidation of plasma cysteine/cystine (Cys/CySS) redox potential (EhCySS) has been
associated with risk factors for cardiovascular disease in humans. Cys and CySS are derived from
dietary sulfur amino acids (SAA), but the specific effects of SAA depletion and repletion on Cys/
CySS redox indices are unknown. The present study examined the effect of dietary SAA intake
level on free Cys, free CySS and EhCySS in human plasma under fasting conditions.
Research Methods and Procedures—Healthy individuals aged 18–36 y (n=13) were
equilibrated to foods providing the RDA for SAA and then fed chemically defined diets without
SAA (0 mg·kg−1·d−1; n=13) followed by SAA at levels approximating the mean (56 mg·kg−1·d−1;
n=8) or 99th percentile (117 mg·kg−1·d−1; n=5) intake levels of Americans. Fasting plasma
samples were collected daily during 4-d study periods and analyzed for free Cys, free CySS and
the EhCySS.
Results—The SAA-free diet significantly (p<0.05) decreased plasma free Cys concentrations
and oxidized EhCySS values after 4 days of SAA depletion. With SAA repletion at 56
mg·kg−1·d− 1, plasma free Cys increased significantly and values for EhCySS became more
reducing. Administration of a diet providing a higher dose of SAA (117 mg·kg−1·d−1) resulted in a
significantly higher level of free Cys and a more reducing EhCySS.
Conclusions—These results show that free Cys and Cys/CySS redox potential (EhCySS) in
fasting plasma are affected by dietary SAA intake level in humans. Significant changes occur
slowly over 4 days with insufficient SAA intake, but rapidly (after 1 day) with repletion.
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Introduction
Proteins contain Cys residues which readily undergo reversible oxidation-reduction
reactions. In vitro studies show that controlled variation in extracellular thiol/disulfide redox
state alters cell signaling of monocyte adhesion to endothelial cells [1], platelet activation
[2], cell proliferation [3,4] and apoptosis [5] apparently mediated through integrins,
metalloproteinases, growth factor receptors and ion channels. In vivo studies in humans
show that oxidized thiol/disulfide redox potential is associated with increased carotid intima
media thickness [6], decreased flow mediated dilation [7], reversible myocardial perfusion
defects [8] and persistent atrial fibrillation [9]. Thus, the dietary factors affecting
extracellular thiol/disulfide redox potential in human plasma could be important in
cardiovascular disease.
The predominant low molecular weight thiol/disulfide system present in plasma is cysteine/
cystine (Cys/CySS). CySS concentration in human plasma is considerably higher than Cys
concentration under most conditions [10–12], and accumulating evidence indicates that the
balance between Cys and CySS could be an important health determinant. Because the
stoichiometry is 2 Cys per CySS, the balance is often expressed in terms of the redox
potential (EhCySS). The reducing force of the plasma Cys/CySS couple is quantitatively
expressed by its redox potential (EhCySS), related to Cys and CySS concentrations by the
Nernst equation [13]. EhCySS in healthy individuals aged 25–35 y was found to be −80 ± 9
mV [10], and cross-sectional studies show that this value is more positive (oxidized) in
association with aging [14], cigarette smoking [15], chronic alcohol abuse [16] and
anticancer therapy [17]. Increased plasma CySS concentration and/or oxidized plasma
EhCySS have been associated with human disease risk, e.g., persistent atrial fibrillation [9],
peripheral vascular disease [6] and age-related macular degeneration [18].
In a study of dietary intake of SAA in rats, we found that SAA-deficient food (providing no
Cys and 17% of control diet SAA intake as Met) resulted in oxidation of plasma EhCySS,
with corresponding changes in gut GSH/GSSG redox potentials and cell growth indices
[19]. A study of diurnal variation of GSH and Cys in human plasma showed that plasma
EhCySS varied in an apparent meal-related pattern [20]. EhCySS was maximally oxidized at
early hours of the morning (0430–0630 AM), became transiently reduced 2–3 h after each
meal, and was maximally reduced at 2030, which was 3 h after the largest meal [20].
Together, these data suggest that in humans, EhCySS could vary as a consequence of dietary
intake of SAA.
The present study was designed to determine the effects of dietary SAA depletion and
repletion on the fasting plasma cysteine/cystine redox potential in humans. The study used a
semisynthetic, chemically defined diet design based upon the studies of Young and
coworkers [21,22], which allows specific changes in L-amino acid content. To minimize
contributions of other environmental factors which could affect oxidative stress and thereby
alter EhCySS, fasting plasma levels were obtained at a consistent time in the controlled
setting of a metabolic research unit.
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Sodium heparin, bathophenanthroline disulfonate sodium salt (BPDS), sodium iodoacetate,
dansyl chloride, L-serine, Cys, CySS, and sodium acetate trihydrate were from Sigma
Chemical Corp. (St. Louis, MO, USA). γ-Glutamylglutamate (γ-Glu-Glu) was from MP
Biomedicals Corp. (Irvine, CA, USA). Boric acid, sodium tetraborate, potassium tetraborate,
perchloric acid, and acetic acid were reagent grade and purchased locally. Methanol,
acetone, and chloroform were HPLC grade.
Subjects
This study was reviewed and approved by the Emory Investigational Review Board. A total
of 13 volunteers, self-described as healthy, were recruited beginning January 1, 2005 by
posting fliers in public locations in the Atlanta/Emory University community. Following
informed consent, all subjects were screened in the outpatient unit of the Emory University
Hospital GCRC, where a medical history and physical examination, body height and weight,
fasting standard blood chemistry and hematology tests and a urinalysis were performed (a
serum pregnancy test was also performed in females). Indirect calorimetry was used to
determine resting energy expenditure (REE). Eligibility was established by the absence of
evidence of acute or chronic illness, no current smoking history, and a body mass index
(BMI) < 30.
Within one month following screening, the subjects were scheduled to begin the study.
Subjects taking antioxidants, nutrient supplements (with the exception of once-daily
multivitamin-mineral supplements) or acetaminophen were asked to discontinue these two
weeks prior to the onset of the studies. A 3-day equilibration period was used to normalize
the 13 subjects with regard to diet (Figure 1). During equilibration, the standardization diet
was based on the U.S. Recommended Dietary Allowances [23] providing maintenance
energy and protein intake, approximating the RDA for SAA intake (12.2 mg/kg body weight
Met per day plus 6.6 mg/kg body weight Cys per day). During the subsequent study periods,
the subjects were given chemically defined oral diets providing maintenance energy intake
and 1.0 g/kg body weight/day protein equivalents as an L-amino acid mixture (Figure 1, see
below). All study meals were prepared in the GCRC metabolic kitchen, given at
standardized mealtimes and consumed over 20 min, and intake was monitored by the GCRC
Bionutrition Unit staff. The study period consisted of two consecutive 4-day study periods.
During the first phase, all subjects received a chemically defined diet devoid of Met and Cys
(SAA depletion phase). This period was followed by an SAA repletion phase which was
isocaloric based upon gross energy content and isonitrogenous with the chemically defined
diets providing either 56 mg/kg body weight SAA per day (n=8) or 117 mg/kg body weight
per day (n=5) respectively (Figure 1). The chemically defined diets contained a distribution
of Met:Cys of 2:1 by gravimetric weight. The intake of 56 and 117 mg/kg body weight SAA
per day levels approximate the mean and 99th percentile daily intake of SAA in the
American diet, respectively, as determined in the National Health and Nutrition Examination
Survey (NHANES III) [23]. Overnight fasted plasma was obtained at 0830 AM for study
endpoints.
Diet and nutrient intake
The protein equivalents of diets were supplied in the same forms of specific L-amino acid
mixtures (Ajinomoto USA, Teaneck, NJ), providing 1.0 g/kg body weight per day as
outlined in detail [21,22]. The standard mixture was patterned after hen’s egg protein and
provides all 9 indispensable (essential) amino acids, including Met, in amounts sufficient for
the mean requirements of healthy young adults [21,22], but which are higher than the
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requirements proposed by the World Health Organization [21,24]. The standard amino acid
mixture also contained 9 dispensable (non-essential) amino acids, including Cys and
glutamate, and was glutamine- and taurine-free. To compensate for the difference in Met +
Cys between the 0, 56 and 117 mg/kg body weight per day SAA diets, the amount of all
non-essential amino acids were proportionally changed to maintain a constant dietary
nitrogen content while at the same time maintaining them as isoenergetic. Similarly, for all
diets, the proportion by gravimetric weight of Met:Cys was constant (2:1). To improve
palatability, a powdered flavoring agent was added to the liquid amino acid mixture
(provided as a sherbet-based drink) (19,20). The Cys was added immediately prior to
consumption to minimize Cys oxidation to CySS prior to consumption. The dietary energy
(1.3 times measured REE) was mainly derived from lipid and carbohydrate sources provided
in the form of protein-free wheat starch and butter/safflower oil cookies and a sherbet-based
drink, as outlined [21,22]. All subjects were completely compliant with all research meals as
verified by the GCRC bionutrition staff.
Adequate oral hydration and vitamin, mineral and electrolyte requirements were provided to
all subjects to meet or exceed recommended allowances [21]. Water was provided ad
libitum with monitoring to ensure urine output of at least 700 mL during each 24-h period.
All subjects received on a daily basis one multivitamin-multimineral capsule with iron (One-
A-Day; Miles Inc., Elkhart, IN); three potassium tablets (K-LYTE;20 meq each, generic);
four calcium tablets (TUMS; SKB Corp., Pittsburgh, PA); two sodium chloride tablets (1
gram tablets; Eli Lilly and Co., Indianapolis, IN); two choline capsules (250-mg; Lee
Nutrition Inc., Cambridge, MA); and one magnesium oxide tablet (400 mg). All
supplements were administered on a regular schedule by the GCRC research nurses. Stool
softener (oral docusate) was provided as needed to a few subjects. Body weights were
determined daily and vital signs were obtained every 8 h. Low-level activity was allowed
and restricted to walking on the GCRC.
Sampling and redox analyses of EhCyS and EhGSSG
Blood was collected at 0830 AM each day of the depletion and repletion period before the
morning meal being provided using a standardized and validated procedure for the further
analyses of free Cys, CySS, GSH, and GSSG. The blood (1.35 mL) was collected via a
heparinized 5 mL syringe with a butterfly needle and immediately transferred to a
microcentrifuge tube containing 0.15 mL of preservation solution designed to alkylate Cys
and prevent its oxidation. The preservation solution included 0.504 mol/L L-serine, 9.3
mmol/L batho-phenanthroline disulfonic acid disodium salt(BPDS), 0.165 mol/L γ-
glutamylglutamate, 0.401 mol/L boric acid, 0.144 mol/L iodoacetic acid, and 2.5 mg (per
mL) heparin. The BPDS, a chelator, was added to minimize autoxidation. The serine and
borate were included to inhibit γ-glutamyltranspeptidase and to buffer pH to a value where
iodoacetate rapidly carboxymethylated thiols. These samples were immediately centrifuged
in a microcentrifuge at 13,000 g for 30 s, and 200 μL of plasma was aliquoted to a tube
containing 10% ice-cold perchloric acid and 0.2 mol/L boric acid solution. The entire
sampling procedure took less than 2 min for each sample, avoiding artifacts from delays in
processing [12]. Samples were stored at −80° C and analyzed within 1 month. Stability tests
showed that samples are stable under these conditions for at least 2 months [25].
A 300-μl aliquot of each supernatant was transferred to a fresh microcentrifuge tube. The pH
was adjusted to 9.0 ± 0.2 with a KOH/tetraborate solution. After 20 min, 300 μl of the
dansyl chloride solution was added, and the samples were mixed and placed in the dark at
room temperature for 16 to 26 h. Chloroform (500 μl) was then added to each tube to extract
the unreacted dansyl chloride, and samples were assayed by HPLC [25].
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EhCySS was calculated using the Nernst equation, Eh = Eo + RT/nF ln[CySS]/([Cys]2),
where Eo is the standard potential (−250 mV for CySS/Cys at pH 7.4), R is the gas constant,
T is the absolute temperature, n is 2 for the number of electrons transferred, and F is
Faraday’s constant [10]. Protein cysteinylation was found to correlate with plasma CySS and
was not measured in the current study [10]. In previous studies of subjects with both normal
homocysteine and homocysteinemia, total free and protein-bound homocysteine have been
shown to correlate [26]. In the current study, study subjects were not screened for
homocysteinemia. EhGSSG was calculated as above using respective GSH and GSSG
concentrations and an Eo of −264 mV for pH 7.4.
Statistics
Minitab software (version 15; Minitab, Inc, State College PA) was used for all analyses. The
protocol was designed so that each individual was studied without SAA (depletion) and with
either 56 or 117 mg·kg−1·d−1 (repletion). With this design, all 13 subjects were treated
identically for the first study period but differed in dose for the second study period. The
fasting morning blood sample immediately following the 3-day equilibration phase
represented the baseline sample for the SAA depletion period (day 0). The subsequent four
fasting morning samples represented the SAA depletion phase (depletion days 1–4; Figure
1). The fasting morning blood sample following the SAA depletion represented the baseline
timepoint for the SAA repletion phase (day 0 of repletion phase). The subsequent four
fasting morning samples represented the SAA repletion phase (repletion days 1–4; Figure 1).
One-way ANOVA was used to evaluate effects of time on plasma Cys, CySS and EhCySS
in all 13 subjects during SAA depletion. One way ANOVA was also used to assess the
effects of SAA repletion of redox indices within the lower SAA repletion dose group (n = 8
for the 56 mg·kg−1·d−1). To assess possible SAA repletion dose-responses, we performed
two-way repeated measures ANOVA to compare the repletion data between the 8 subjects
receiving SAA repletion at 56 mg·kg−1·d−1 versus the 5 subjects receiving SAA repletion at
117 mg·kg−1·d−1. Tukey simultaneous tests were used for post-hoc comparisons. Data are
expressed as mean ± SEM. Results were considered significant at P ≤ 0.05.
Results
Study subject characteristics
Thirteen subjects aged 18 to 36 y were studied, eight in Group 1 with 56 mg/kg body weight
SAA (18.7 mg/kg Cys) and five in Group 2 with 117 mg/kg body weight SAA (39 mg/kg
Cys) daily intake (see Table 1). The 13 subjects included 8 males and 5 females, with 6
Whites, 5 African-Americans, 1 Asian and 1 other. Groups 1 and 2 did were not different in
mean age (± SEM) at 23.6 ± 2.7 y and 24.9 ± 2.2 y, respectively. BMI ranged from 20 to 26
with mean (± SEM) values of 22.5 ± 1.8 and 22.5 ± 1.5, for Groups 1 and 2, respectively,
and were not statistically different. Subjects reported no acute or chronic illness and none
were taking regular prescription medications.
Effect of SAA depletion on plasma free Cys, free CyS and EhCyS
At baseline (following equilibration with the 18.7 mg·kg−1·d−1 SAA diet), the mean fasting
Cys value was 10.6 ± 0.6 μmol/L for all 13 subjects (Fig 2A). The free Cys concentrations
by one-way ANOVA decreased with time during SAA depletion phase (Fig 2A; p <0.05)
with the minimum value occurring after 4 days (7.6 ± 0.4 μmol/L). The free Cys values were
significantly different from baseline on days 2 to 4 by post-hoc testing (Fig 2A). The data
show a gradual plasma free Cys decrease occurs with an approximate rate of 0.6 μmol/L per
day.
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The free CySS concentration in fasting plasma at baseline was (74 ± 5 μmol/L). Plasma free
CySS concentrations did not change significantly over time in subjects fed the SAA depleted
diet (Fig 2B).
Fasting plasma EhCySS was −75 ± 2 mV (n = 13) at baseline. This value is similar to the
previously reported mean values of −72 to −77 mV for fasting samples taken between 06:30
AM and 08:30 AM in a diurnal variation study [20]. EhCySS became significantly more
positive (less reducing) during the SAA-depletion period, with values at day 4 (−67 ± 2)
significantly more oxidized than baseline and depletion day 1 values by post-hoc testing (p <
0.05) (Fig 2C).
Effect of SAA repletion on plasma free Cys, free CyS and EhCyS
The effects of dietary SAA repletion on plasma Cys/CySS redox was determined in 8 of the
13 subjects studied above. These individuals were fed isoenergetic, isonitrogenous,
chemically defined diets providing SAA intake approximating the mean American intake
(56 mg·kg−1·d−1) from NHANES III) [27]. Figure 3 shows the free Cys values in fasting
plasma for these 8 subjects during their SAA repletion phase. SAA at this dose significantly
increased plasma free Cys concentrations over time (Figure 3A; P<0.005), with values rising
significantly above the post-depletion baseline values by day 1 of SAA repletion and then
plateauing by day 2 of repletion. Plasma free CySS levels did not change during SAA
repletion (Figure 3B). However, due to the increase in plasma free Cys, the EhCySS became
more reducing during repletion over time from the post-depletion baseline value of −70 ± 3
mV (P<0.05) (Figure 3C). The most reduced values occurred by day 2 of SAA repletion
(−81 ± 2 mV; P < 0.05 versus baseline).
SAA repletion dose-responses
To explore potential dose-response effects of SAA repletion on the free Cys, free CySS and
EhCySS in fasting plasma, we compared the repletion data between the 8 subjects receiving
SAA repletion at 56 mg·kg−1·d−1 and the 5 subjects receiving SAA repletion at 117
mg·kg−1·d. Two-way repeated measures ANOVA were performed to determine the dose
response of SAA on free Cys, free CySS and EhCySS. This repeated measures ANOVA
showed the increase in plasma free Cys concentrations over time with the higher SAA
repletion dose was marginally significant compared to the lower dose (p=0.055) (Figure
4A). In contrast, plasma free CySS levels were not statistically different with the lower
versus the higher SAA repletion doses (Figure 4B). Redox potential (EhCySS) for the Cys-
CySS couple was significantly affected by SAA repletion dose; the values for EhCySS were
more reducing with the 117 mg·kg−1·d SAA repletion dose over time compared to the 56
mg·kg−1·d− dose (Figure 4C).
Effects on free GSH redox couple in fasting plasma
For all conditions described, analyses were also performed to determine free GSH, free
GSSG and the redox potential for the GSH/GSSG couple (EhGSSG). These data showed the
GSH and GSSG concentrations were comparable to those obtained previously for baseline
of fasting morning conditions (GSH: 1.6 ± 0.2 μmol/L, GSSG:0.08 ± 0.03 μmol/L expressed
as mean ± SEM) [25]. The plasma free GSH did not change during depletion and repletion
period (Figure 5). No significant effect of SAA intakes on GSSG or EhGSSG in fasting
plasma was detected (data not shown).
Discussion
Accumulating evidence indicates that plasma GSH/GSSG and Cys/CySS pools could be
important in disease risk in humans and be especially relevant to cardiovascular disease as
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possible biomarkers of risk. For instance, both EhGSSG and EhCySS were found to be
oxidized in association with age [14], cigarette smoking [15] and increased BMI [7].
EhGSSG was also found to be oxidized in association with type 2 diabetes [28] and alcohol
abuse [16], and EhCySS was oxidized in association with increased proinflammatory
cytokines, IL-1β and TNF-α [29], and reduced in individuals consuming a Mediterranean
diet [30]. The concentration of CySS, which is a co-variable with EhCySS, is also increased
in association with TNF-α [29], endothelial dysfunction [7], and increased carotid intima
media thickness [6]. In addition, a substantial literature shows that dietary inducers can
affect tissue levels of GSH and related metabolites [31]. Thus, there is a need to understand
dietary factors which affect plasma EhGSSG, EhCySS or CySS concentration in humans.
The present study addressed whether recent history of dietary sulfur amino acid intake
affected fasting plasma EhGSSG, EhCySS or CySS concentration. The data show no
significant effects on EhGSSG or CySS concentration. However, the results show that low
SAA intake decreased fasting blood levels of free Cys and resulted in an oxidation of
EhCySS over a period of 4 days. In contrast, 1 day with SAA at the mean American intake
level was sufficient to restore the free Cys and EhCySS in fasting plasma. These data
indicate that if fasting plasma EhCySS is used for assessment of cardiovascular disease risk,
the previous 24-h intake of SAA could mask oxidation due to a long-term inadequate SAA
intake. On the other hand, surveillance data show that long-term inadequate SAA intake is
not common [27], and 1 day of inadequate SAA intake is not sufficient to result in a falsely
oxidized EhCySS value. Thus, although variations in recent history of SAA intake can affect
EhCySS, this effect is insufficient to seriously compromise use of EhCySS as a biomarker.
The lack of effects of SAA intake on fasting plasma EhGSSG and CySS concentration
indicate that these parameters are minimally affected by the recent history of SAA intake.
In vitro studies indicate that oxidation of plasma EhCySS could be mechanistically
important in disease development. While plasma EhGSSG is thought to indicate tissue
oxidative stress, EhCySS appears to reflect extracellular oxidative processes [14]. A more
oxidized EhCySS in culture media was found to increase sensitivity of retinal pigment
epithelial cells [5] and endothelial cells (Y-M Go and DP Jones, unpublished observation) to
apoptosis, enhance binding of monocytes [1,32] and neutrophils [33] to endothelial cells and
increase production of proinflammatory cytokines in monocytes [29]. At least some of these
effects are mediated through cell surface thiols [1], indicating that oxidation of plasma thiol/
disulfide couples could directly affect function of extracellular or cell surface proteins,
including receptors, integrins and metalloproteinases [34].
The magnitudes of the diet-induced changes after 4 d further suggest that fasting plasma
EhCySS could be mechanistically important in cell signaling through cell surface protein
dithiol/disulfide couples; an 8 mV oxidation in EhCySS (as observed after 4 days of SAA
depletion) is equivalent to an approximately 2-fold change in protein dithiol/disulfide ratio
while an 18 mV change (difference between 4 d with high SAA versus no SAA) is
equivalent to a 4- fold change [35]. The magnitude of the EhCySS oxidation observed with
SAA depletion is similar to differences associated with aging [14,18], smoking [15], or
alcohol consumption [16]. Also, the mean difference in EhCySS for individuals with high
and low risk of persistent atrial fibrillation was 10 mV [9]. The similarities in magnitude of
EhCySS in these disorders and with SAA depletion in the present study suggest that diet-
induced changes at extreme levels of SAA intake may have pathophysiologic effects.
Deficient intake of SAA could have effects other indirect effects. For instance, taurine, a
product of Cys oxidation, was found to protect against hyper-homocysteinemia-induced
toxicity apparently through an antioxidant mechanism [36]. Insufficient intake could also
have effects through altered transport of Cys and CySS in vivo because the transporters for
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these amino acids are common to other amino acids. Changes in SAA would thereby affect
the balance of amino acids required for cellular protein synthesis. Furthermore, the GSH
turnover is decreased by SAA intake [21,22], indicating that transport of precursors could be
limiting. In vitro studies show that culture of HT29 cells in Cys- and CySS-free media
results in oxidation of the cellular EhGSSG and increased GSH synthesis upon re-addition of
the amino acids to the culture media [11]. The xc− system functions in uptake of CySS and
is transcriptionally induced through the Nrf-2 transcription factor by oxidative conditions
[11]. Thus, it appears likely that altered transport occurs in response to SAA insufficiency.
The present study of healthy, young individuals does not allow conclusions concerning older
individuals who are more at risk of disease. The present study included young, healthy
individuals, but clinical data for EhCySS and disease largely include middle age and older
individuals. Some of these latter studies provide stronger associations of disease risk with
the free CySS concentration than with EhCySS [6,37,38]. Thus, experiments are warranted
to determine whether similar or greater effects on the free CySS and EhCySS occur in older
individuals and in individuals with disease risk.
In conclusion, the data show that for young adults with previously sufficient SAA intake, the
free Cys, free CySS and EhCySS in fasting plasma are affected by SAA intake over a 4-day
period. The results show that SAA repletion rapidly improves Cys/CySS redox status
(within 24 h) after a diet devoid of methionine, cysteine or cystine. The magnitude of
differences between intake of insufficient and sufficient diets were similar to previously
reported differences associated with aging, oxidative stress and disease, suggesting that SAA
intake at extreme levels could contribute to disease processes associated with these redox
parameters.
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Fig 1. Study scheme for dietary sulfur amino acid (SAA) effects on plasma cysteine, cystine and
cysteine/cystine redox potential
The 13 healthy adult study subjects were each admitted into the Emory General Clinical
Research Center (GCRC) for a 13-day inpatient study period. The first 3 days were an
equilibration phase, during which conventional food items approximating the RDA for SAA
(18.7 mg·kg−1) were given. The subjects were given chemically defined oral diets for a
subsequent 10-day study period providing maintenance energy intake and 1.0 g/kg body
weight/day protein equivalents. During the study period without SAA, all 13 subjects were
fed a chemically defined diet devoid of Met and Cys (SAA insufficiency phase). This was
followed by a SAA repletion phase during which the chemically defined diet providing
either 56 mg SAA per kg body weight per day (n=8), similar to average SAA intake based
on U.S. consumption data, or 117 mg·kg−1·d−1 SAA (n=5), similar to 99 percentile intake of
Americans, was given. Protein equivalents were provided as an L-amino acid mixture
containing 9 essential amino acids, without or with methionine (Met) and 9 non-essential
amino acids, without or with cysteine (Cys). The SAA repletion diets were made isocaloric
and isonitrogenous to the SAA insufficient diet by proportional adjustment of the 9 non-
essential amino acids in the L-amino acid mixture. Arrows designate time points for
overnight fasting plasma sample collection for free Cys, free CySS and EhCySS, which were
obtained at 0830 AM.
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Fig 2. The free cysteine (Cys), free cystine (CySS) and Cys/CySS redox potential (EhCySS) in
human plasma under fasting conditions following intake of SAA-free diet
The study protocol is as outlined in Figure 1. Data shown are derived from fasting plasma
samples (n=8) obtained at morning time points after completion of the equilibration period
and for the next 4 days during consumption of diets devoid in methionine, Cys and CySS. A.
The free Cys in fasting plasma. A significant effect of time was observed by one-way
ANOVA (P<0.05). *Significant difference from baseline values (P<0.05). B. The free CySS
in fasting plasma. No change over time was observed. C. Fasting plasma EhCySS. A
significant effect of time was observed by one-way ANOVA (P<0.05). *Significant
difference from baseline values and #from day 1 values by Tukey’s post-hoc test (P<0.05).
Data are expressed as mean ± SEM.
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Fig 3. Free Cys, free CySS and EhCySS in human plasma obtained under fasting conditions
following SAA repletion
The study protocol is as outlined in Figure 1. Data shown are derived from fasting plasma
samples (N = 8) obtained at morning time points following completion of SAA depletion
period and for the next 4 days during repletion with diets providing 56 mg·kg−1·d−1 SAA.
A. The free Cys in fasting plasma. A significant effect of time was observed by one-way
ANOVA (P<0.05). *Significant difference from baseline values (P<0.05). B. The free CySS
in fasting plasma. No change over time was observed. C. Fasting plasma EhCySS. A
significant effect of time was observed by one-way ANOVA (P<0.05). *Significant
difference from baseline values by Tukey’s post-hoc test (P<0.05). Data are expressed as
mean ± SEM.
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Fig 4. Dose response to SAA repletion on free Cys, free CySS and EhCySS in human fasting
plasma following SAA repletion
The study protocol is as outlined in Figure 1. Data shown are derived from fasting plasma
samples obtained at morning time points following completion of SAA depletion period and
for the next 4 days during repletion with diets providing either 56 mg·kg−1·d−1 SAA (solid
lines: n=8) or 117 mg·kg−1·d−1 SAA (dotted line: n=5). A. The free Cys in fasting plasma. A
trend for an effect of SAA dose was observed by two-way repeated measures ANOVA
(P=0.055). B. The free CySS in fasting plasma. No significant effect of SAA dose was
observed by two-way repeated measures ANOVA. C. Fasting plasma EhCySS. A significant
effect of SAA dose was observed by two-way repeated measures ANOVA (P<0.05). Data
are expressed as mean ± SEM.
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Fig 5. Dose response of SAA repletion on free GSH in human fasting plasma following SAA
repletion
The study protocol is as outlined in Figure 1. Data shown are derived from fasting plasma
samples obtained at morning time points from baseline (completion of SAA depletion
period, closed circle, dotted line) and for the next 4 days during repletion with diets
providing either 56 mg·kg−1·d−1 SAA (closed triangle, solid lines: n=8) or 117 mg·kg−1·d−1
SAA (open triangle, dotted line: n=5). No significant effect of SAA dose was observed by
two-way repeated measures ANOVA. Data are expressed as mean ± SEM.
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TABLE 1
Characteristics of the study participants
Group 1: Subjects receiving sulfur amino acids at 56 mg·kg−1·d−1
Age Sex Race BMI
18 F White 22.5
20 M White 22.3
21 M Black 20.7
23 F Black 24.8
23 M White 23.2
25 M Asian 21.0
33 F Black 26.0
36 M Black 20.0
Group 2: Subjects receiving sulfur amino acids at 117 mg·kg−1·d−1
Age Sex Race BMI
18 F White 26.3
19 M Other 23.6
21 F Black 20.3
29 M White 24.7
31 M White 25.6
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